arginine vasopressin has been researched along with ursodeoxycholic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Grune, S; Jameson, HL; Myers, NC; Sawkat-Anwer, M | 1 |
1 review(s) available for arginine vasopressin and ursodeoxycholic acid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for arginine vasopressin and ursodeoxycholic acid
| Article | Year |
|---|---|
cGMP stimulates bile acid-independent bile formation and biliary bicarbonate excretion.
Topics: 1-Methyl-3-isobutylxanthine; 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Amiloride; Animals; Arginine Vasopressin; Bicarbonates; Bile; Bile Acids and Salts; Calcium; Cells, Cultured; Choline; Cyclic AMP; Cyclic GMP; Glutathione; Hydrogen-Ion Concentration; In Vitro Techniques; Kinetics; Liver; Male; Oxygen Consumption; Rats; Rats, Wistar; Taurocholic Acid; Thionucleotides; Ursodeoxycholic Acid | 1996 |